Electronic screening of medical records to detect inpatients at risk of drug-related problems

Pharmacy World and Science

Volumn 32, Issue 1, 2010, Pages 103-107

  Roten, Isabelle ^a   Marty, Stefan ^b   Beney, Johnny ^b  

^a Pharmacie des Hôpitaux du Nord Vaudois et de la Broye PHNVB   (Switzerland)

^b Institut Central des Hopitaux Valaisans   (Switzerland)

Author keywords

Drug therapy; Drug utilization review; Medical records systems, computerized; Pharmaceutical services; Pharmacists; Workload

Indexed keywords

ACENOCOUMAROL; ANTIINFECTIVE AGENT; CARBAMAZEPINE; CLARITHROMYCIN; DIGOXIN; ERYTHROMYCIN; FLUCONAZOLE; ISONIAZID; METHOTREXATE; PARACETAMOL; PHENOBARBITAL; PHENPROCOUMON; PHENYTOIN; POTASSIUM; PRIMIDONE; RIFAMPICIN;

ARTICLE; CLINICAL PHARMACY; DRUG INDUCED DISEASE; DRUG USE; ELECTRONIC MEDICAL RECORD; HOSPITAL PATIENT; HUMAN; HYPERICUM PERFORATUM; PHARMACIST; SCREENING; SENSITIVITY AND SPECIFICITY; WORKLOAD;

DRUG MONITORING; DRUG THERAPY; DRUG TOXICITY; DRUG UTILIZATION REVIEW; ELECTRONIC HEALTH RECORDS; HUMANS; INPATIENTS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 75949130572     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-009-9352-6     Document Type: Article

References (21)

1. Pharmaceutical Care Network Europe. DRP-classification V5.01. 2009. http://www.pcne.org/dokumenter/DRP/PCNE%20classification%20V5.01.pdf. Accessed Aug 2009.
2. A Krähenbühl-Melcher R Schlienger M Lampert M Haschke J Drewe S Krähenbühl 2007 Drug-related problems in hospitals-a review of the recent literature Drug Saf 30 379 407 10.2165/00002018-200730050-00003 17472418 (Pubitemid 46740336)
3. A Spinewine S Dhillon L Mallet PM Tulkens L Wilmotte C Swine 2006 Implementation of ward-based clinical pharmacy services in Belgium-description of the impact on a geriatric unit Ann Pharmacother 40 4 720 728 10.1345/aph.1G515 16569792
4. Eviter les effets indésirables par interactions médicamenteuses. Prescrire, Le Guide 2008. 2007;27(290):1-208.
5. JE Murphy DC Malone BM Olson AJ Grizzle EP Armstrong GH Skrepnek 2009 Development of computerized alerts with management strategies for 25 serious drug-drug interactions Am J Health Syst Pharm 66 1 38 44 10.2146/ajhp070046 1:CAS:528:DC%2BD1MXhs1Gmtro%3D 19106343
6. W Harris 2004 Methotrexate-associated medication errors Am J Health Syst Pharm 61 24 2635 15646698
7. TJ Moore CS Walsh MR Cohen 2004 Reported medication errors associated with methotrexate Am J Health Syst Pharm 61 13 1380 1384 15287234
8. DW Cockcroft MH Gault 1976 Prediction of creatinine clearance from serum creatinine Nephron 16 1 31 41 10.1159/000180580 1:STN:280:DyaE28%2FnsF2isw%3D%3D 1244564
9. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002; 39(2 Suppl 1):S1-S266.
10. EA van Dijk NR Drabbe M Kruijtbosch PA De Smet 2006 Drug dosage adjustments according to renal function at hospital discharge Ann Pharmacother 40 7-8 1254 1260 16804098
11. NA Wong HW Jones 1998 An analysis of discharge drug prescribing amongst elderly patients with renal impairment Postgrad Med J 74 873 420 422 10.1136/pgmj.74.873.420 1:STN:280:DyaK1M%2Fhs1aquw%3D%3D 9799917
12. L Salomon G Deray MC Jaudon C Chebassier P Bossi V Launay-Vacher, et al. 2003 Medication misuse in hospitalized patients with renal impairment Int J Qual Health Care 15 4 331 335 10.1093/intqhc/mzg046 1:STN:280:DC%2BD3szpt1Kjug%3D%3D 12930048 (Pubitemid 36987271)
13. MR Mordasini S Krähenbühl RG Schlienger 2002 Appropriateness of digoxin level monitoring Swiss Med Wkly 132 35-36 506 512 1:CAS:528: DC%2BD3sXmvVSitw%3D%3D 12506332
14. JK Aronson M Hardman 1992 ABC of monitoring drug therapy. Digoxin BMJ 305 6862 1149 1152 10.1136/bmj.305.6862.1149 1:STN:280:DyaK3s%2FpvFertA%3D%3D 1463955
15. V von Gunten V Amos AL Sidler J Beney N Troillet JP Reymond 2003 Hospital pharmacists' reinforcement of guidelines for switching from parenteral to oral antibiotics: a pilot study Pharm World Sci 25 2 52 55 10.1023/A:1023240829761 (Pubitemid 36547113)
16. Bensimon E, Marty S, Theytaz C, Frasseren M, Eckert P, Beney J. Réduction des coûts du paracétamol dans une unité de soins intensifs [Poster]. Quatorzièmes journées franco-suisses de pharmacie hospitalière, Lausanne, 2007.
17. S Ruths J Straand HA Nygaard 2003 Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study Qual Saf Health Care 12 3 176 180 10.1136/qhc.12.3.176 1:STN:280:DC%2BD3s3ms1Whtw%3D%3D 12792006
18. JT Hanlon MB Artz CF Pieper CI Lindblad RJ Sloane CM Ruby KE Schmader 2004 Inappropriate medication use among frail elderly inpatients Ann Pharmacother 38 1 9 14 10.1345/aph.1D313 14742785
19. SR Jones S Carley M Harrison 2003 An introduction to power and sample size estimation Emerg Med J 20 5 453 458 10.1136/emj.20.5.453 1:STN:280:DC%2BD3svhsFarug%3D%3D 12954688
20. NM Buderer 1996 Statistical methodology: I. Incorporating the prevalence of disease into the sample size calculation for sensitivity and specificity Acad Emerg Med 3 9 895 900 10.1111/j.1553-2712.1996.tb03538.x 1:STN:280: DyaK2s%2FisVGgtA%3D%3D 8870764
21. IK Bindoff PC Tenni GM Peterson BH Kang SL Jackson 2007 Development of an intelligent decision support system for medication review J Clin Pharm Ther 32 1 81 88 10.1111/j.1365-2710.2007.00801.x 1:STN:280:DC%2BD2s%2FovFWrtQ%3D%3D 17286791 (Pubitemid 46213943)